Y-Intercept (HK) Portfolio holdings
Y-Intercept is a Hong Kong hedge fund firm that trades with computer-driven models, backed by Schonfeld Strategic Advisors. Its main strategy is statistical arbitrage across global stocks and related instruments. For years it managed money only for Schonfeld, until it opened its first fund to outside investors in 2025. That fund also adds macro strategies, so the firm can trade equities, interest rates, currencies and commodities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allstate
ALL
|
+$66.6M |
| 2 |
TSMC
TSM
|
+$34.9M |
| 3 |
Shopify
SHOP
|
+$29.2M |
| 4 |
Bank of America
BAC
|
+$28.4M |
| 5 |
Aon
AON
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$49.6M |
| 2 |
Boston Scientific
BSX
|
+$46M |
| 3 |
Microsoft
MSFT
|
+$44.5M |
| 4 |
Salesforce
CRM
|
+$37.3M |
| 5 |
Cognizant
CTSH
|
+$34.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 15.64% |
| 3 | Industrials | 12.53% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ETRA
1451
Electra Therapeutics, Inc. Common stock
ETRA
$511M
| $237K | 0.01% |
+21,103
| New | +$260K |
2026 Q3
0 quarters
|
|
1452
Evolus
EOLS
$439M
| $236K | 0.01% |
+29,508
| New | +$221K |
2026 Q3
0 quarters
|
|
1453
Vanguard Total Bond Market
BND
$166B
| $236K | 0.01% |
3,362
+303
| +10% | +$21.8K |
2026 Q2
1 quarter
|
|
1454
MSC Income Fund Inc
MSIF
$566M
| $234K | 0.01% |
19,889
-8,607
| -30% | -$104K |
2026 Q1
2 quarters
|
|
1455
Root
ROOT
$662M
| $233K | 0.01% |
+5,057
| New | +$280K |
2026 Q3
0 quarters
|
|
1456
Arhaus
ARHS
$2.11B
| $232K | 0.01% |
24,522
-165,020
| -87% | -$1.41M |
2026 Q2
1 quarter
|
|
1457
Privia Health
PRVA
$3.09B
| $231K | 0.01% |
+11,730
| New | +$267K |
2026 Q3
0 quarters
|
|
1458
iShares Core US Aggregate Bond ETF
AGG
$138B
| $227K | 0.01% |
2,398
-1,431
| -37% | -$139K |
2026 Q2
1 quarter
|
|
1459
Select Water Solutions
WTTR
$2.02B
| $226K | 0.01% |
+11,429
| New | +$227K |
2026 Q3
0 quarters
|
|
1460
Consolidated Water Co
CWCO
$420M
| $224K | 0.01% |
+8,011
| New | +$234K |
2026 Q3
0 quarters
|
|
1461
Equinox Gold
EQX
$13.3B
| $224K | ﹤0.01% |
20,158
-68,724
| -77% | -$766K |
2025 Q3
4 quarters
|
|
1462
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.3B
| $224K | ﹤0.01% |
+662
| New | +$231K |
2026 Q3
0 quarters
|
|
1463
Papa John's
PZZA
$673M
| $223K | ﹤0.01% |
+11,332
| New | +$297K |
2026 Q3
0 quarters
|
|
1464
The Honest Company
HNST
$566M
| $223K | ﹤0.01% |
+43,507
| New | +$207K |
2026 Q3
0 quarters
|
|
1465
Private Bancorp of America
PBAM
$496M
| $221K | ﹤0.01% |
+2,596
| New | +$228K |
2026 Q3
0 quarters
|
|
1466
Schwab US TIPS ETF
SCHP
$17.4B
| $220K | ﹤0.01% |
+8,761
| New | +$227K |
2026 Q3
0 quarters
|
|
1467
Usana Health Sciences
USNA
$246M
| $219K | ﹤0.01% |
15,157
+1,182
| +8% | +$20.3K |
2026 Q2
1 quarter
|
|
1468
Capital Group Municipal Income ETF
CGMU
$7.59B
| $219K | ﹤0.01% |
+8,446
| New | +$228K |
2026 Q3
0 quarters
|
|
1469
Malibu Boats
MBUU
$402M
| $219K | ﹤0.01% |
+9,542
| New | +$257K |
2026 Q3
0 quarters
|
|
1470
Associated Banc-Corp
ASB
$5.76B
| $218K | ﹤0.01% |
7,623
-49,332
| -87% | -$1.51M |
2025 Q3
4 quarters
|
|
1471
Relay Therapeutics
RLAY
$4.39B
| $218K | ﹤0.01% |
+12,083
| New | +$231K |
2026 Q3
0 quarters
|
|
1472
T. Rowe Price Small-Mid Cap ETF
TMSL
$3.22B
| $216K | ﹤0.01% |
+5,303
| New | +$227K |
2026 Q3
0 quarters
|
|
1473
DELISTED
Nathan's Famous
NATH
| $214K | ﹤0.01% |
2,108
-4,031
| -66% | -$397K |
2026 Q2
1 quarter
|
|
1474
Brink's
BCO
$4.84B
| $213K | ﹤0.01% |
2,114
-40,929
| -95% | -$4.54M |
2025 Q4
3 quarters
|
|
1475
Artiva Biotherapeutics
ARTV
$198M
| $211K | ﹤0.01% |
+29,633
| New | +$299K |
2026 Q3
0 quarters
|
|
Similar funds
Y-Intercept (HK)'s Q3 2026 Portfolio in Review
As of Q3 2026, Y-Intercept (HK) held 2,238 positions worth $4.52B, down 10% from $5.05B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Y-Intercept (HK) withdrew a net $314M in Q3 2026, closing 706 positions and reducing 464 holdings. Its most notable exit was Microsoft, an estimated $44.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
Against the trend, Y-Intercept (HK) opened a new position in Allstate worth $58.3M.
- Y-Intercept (HK)'s largest Q3 2026 buy was Allstate: 262,728 shares worth $58.3M.
- Y-Intercept (HK) added most to TSMC in Q3 2026, an estimated $34.9M increase.
- Y-Intercept (HK)'s biggest Q3 2026 reduction was Amazon, cutting an estimated $49.6M.
- Y-Intercept (HK) fully exited Microsoft in Q3 2026, selling an estimated $44.5M.
- Y-Intercept (HK)'s ten largest holdings make up 8.2% of its $4.52B portfolio in Q3 2026.
- Y-Intercept (HK) opened 587 new positions and closed 706 in Q3 2026.
- Y-Intercept (HK)'s portfolio value fell 10% quarter-over-quarter to $4.52B.
Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.